Intestinal Akkermansia Muciniphila in Prostate Cancer
Conditions: Metastatic Castration-resistant Prostate Cancer Interventions: Diagnostic Test: Biological samples Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Clinical Application of the J-PET Scanner Prototype
Conditions: Prostate Cancer; Prostatic Hyperplasia; Prostatic Neoplasms; Prostate Cancer Metastatic; Neuroendocrine Tumors; Neuroendocrine Carcinoma Interventions: Diagnostic Test: J-PET scan Sponsors: Jagiellonian University; University Hospital in Krakow Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC) Interventions: Drug: YL201 for Injection Sponsors: MediLink Therapeutics (Suzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
Conditions: Metastatic Solid Tumor; Recurrent Solid Tumor; Advanced Solid Tumor; Urinary Bladder Neoplasm; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Esophageal Cancer; Pancreatic Cancer; Ovarian Cancer; Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Prostate Cancer; Renal Pelvis Cancer; Bladder Cancer Interventions: Drug: LY4101174 Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
Conditions: Prostate Adenocarcinoma; Localized Prostate Carcinoma Interventions: Procedure: Single-port extraperitoneal robotic-assisted radical prostatectomy with Vattikuti Institute Prostatectomy （VIP） techniques; Procedure: Multi-port transperitoneal robotic-assisted radical prostatectomy with bilateral intrafascial nerve-sparing techniques Sponsors: Shanghai Changzheng Hospital; Shanghai Zhongshan Hospital; ShuGuang Hospital; The Third Affiliated Hospital of Naval Medical University; The First Affiliated Hospital of Guangzhou Medical University; Sir Run Run Shaw Hospital; Sichuan Provincial People ' s Hospital Recr...
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)
Conditions: Metastatic Prostate Cancer (PCa) in ADT; Rehabilitation Interventions: Procedure: rehabilitation Sponsors: Azienda Unit à Sanitaria Locale Reggio Emilia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Conditions: Biliary Tract Cancer; Breast Cancer; Cervical Cancer; Colon Cancer; Endometrial Cancer; Esophageal Cancer; Gastric Cancer; GastroEsophageal Cancer; Head and Neck Cancer; Hepatocellular Cancer; Non-small Cell Lung Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Thyroid Cancer Interventions: Drug: MDX2001 Sponsors: ModeX Therapeutics, An OPKO Health Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Prostate Cancer Screening With PSA, Risk Calculator and Multiparametric MRI: a Pilot Study
Conditions: Prostate Cancer Interventions: Diagnostic Test: Urology visit with Risk Calculator and MRI Sponsors: Fondazione del Piemonte per l ' Oncologia; San Luigi Gonzaga Hospital; Epidemiology and Screening Unit - CPO, Turin, Italy Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
Novel Robotic Prostatectomy Technique for Early Urinary Continence
Conditions: Prostate Cancer Sponsors: Sir Mortimer B. Davis - Jewish General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate Cancer
Conditions: Prostatic Neoplasm Interventions: Drug: Ifosfamide/mesna Sponsors: Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Novel Robotic Prostatectomy Technique: Phase II Trial for Early Urinary Continence
Conditions: Prostate Cancer Sponsors: Sir Mortimer B. Davis - Jewish General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Conditions: Prostate Cancer Interventions: Radiation: Radiation; Radiation: Radiation SBRT only Sponsors: Canadian Cancer Trials Group; NRG Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Conditions: Prostate Cancer; Supportive Care Interventions: Behavioral: Exercise Training Intervention; Behavioral: Healthy Living Education Sponsors: Virginia Commonwealth University; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Castration-Resistant Prostate Carcinoma; Metastatic Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Biological: Anti-STEAP1 CAR T-cells; Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Drug: Cyclophosphamide; Procedure: Echocardiography; Drug: Enzalutamide; Drug: Fludarabine; Procedure: Leukapheresis; Procedure: Magnetic Resonance Imaging; Procedure: Multigated Acquisition Scan; Procedure: Positron Emission Tomography Sponsors: Fred Hutchinson Cancer Center; PromiCell Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
The Safety and Dosimetry Study of 177Lu-LNC1003 Injection
Conditions: Metastatic Castration-resistant Prostate Cancer, mCRPC Interventions: Drug: 177Lu-LNC1003 Injection group 1; Drug: 177Lu-LNC1003 Injection group 2; Drug: 177Lu-LNC1003 Injection group 3 Sponsors: Yantai LNC Biotechnology Singapore PTE. LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
